Services for University Research & Licensing
Universities and Teaching Centers have always been a ripe field for biotechnology and life sciences product development. However, not all of the ideas that result in completed intellectual property are commercially viable. Third Trimester is able to assist your licensing and technology transfer offices in evaluating the market viability of these intellectual properties. In addition, we can help you and the companies that are developed through the transfer of these technologies via strategic planning, business development, investment and executive management.
Technology Assessment
It has been our experience that often intellectual properties are developed with one strategic focus and end up in the market place in a totally different manner than what was originally conceived. In order for a University to be able to properly evaluate the potential licensing value of intellectual properties, a thorough market assessment is advised.
Based upon our experiences as entrepreneurs and senior corporate executives, Third Trimester will asses the market viability of your intellectual properties via the following methods.
- Targeted Market Size
- Existing Competitive Environment
- Barriers to Entry
- Strategic Corporate Partners
- Time to Market For Completion of Product or Service Development
- Estimated Costs of Development to Get to Market
- Strength of Intellectual Property
Interim Executive Management
Early stage biotechnology, life sciences, and healthcare companies often need interim management support as they transition into an operating company. During this transition period, the type of management support needed depends upon the required short-term objectives. Some organizations need an experienced interim CEO to provide an executive presence to assist with investment development. Others may require operational management support as they launch manufacturing and marketing efforts. Still, others may need financial management support via an interim CFO to assist with the development of good financial reporting and disciplines.
Early Stage Funding
Third Trimester's approach to the venture market is unique. By using our management interactions as a filter, we identify organizations that have the technology, teams and discipline to be successful. These are the companies that we look to invest in by providing early stage angel funding. This approach provides a seamless transition for early stage funding and allows for little to no interruption from the business development focus. Our early stage investments range between $100,000 and $500,000.